Yaling Shi

InstitutionGuangzhou Medical University
AddressGuangzhou
Guangdong
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 3 publications in July 2021
    All Publications
    Bar chart showing 29 publications over 13 distinct years, with a maximum of 6 publications in 2015
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ou J, Tan M, He H, Tan H, Mai J, Long Y, Jiang X, He Q, Huang Y, Li Y, Chen R, Li L, Shi Y, Li F. SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases. J Appl Lab Med. 2021 09 01; 6(5):1133-1142. PMID: 34329427.
      Citations:    Fields:    Translation:Humans
    2. Zhang J, Lin D, Li K, Ding X, Li L, Liu Y, Liu D, Lin J, Teng X, Li Y, Liu M, Shen J, Wang X, He D, Shi Y, Wang D, Xu J. Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients. Front Immunol. 2021; 12:716075. PMID: 34394120.
      Citations: 1     Fields:    Translation:HumansCells
    3. Lin H, Ma X, Xiao F, Su H, Shi Y, Liu Y, Song L, Zhang Z, Zhang C, Peng H. Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2. FEBS J. 2021 09; 288(17):5163-5178. PMID: 34228902.
      Citations: 1     Fields:    Translation:HumansCells
    4. Teng X, Zhang J, Shi Y, Liu Y, Yang Y, He J, Luo S, Huang Y, Liu Y, Liu D, Li Y, Zhang S, Huang RP, Wang D, Xu J. Comprehensive Profiling of Inflammatory Factors Revealed That Growth Differentiation Factor-15 Is an Indicator of Disease Severity in COVID-19 Patients. Front Immunol. 2021; 12:662465. PMID: 34335566.
      Citations: 1     Fields:    Translation:Humans
    5. Liao B, Liu Z, Tang L, Li L, Gan Q, Shi H, Jiao Q, Guan Y, Xie M, He X, Zhao H, Chen W, Liu Y, Li L, Wang Y, Cao Y, Shi Y, Li Y, Lei C. Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. Int J Med Sci. 2021; 18(1):29-41. PMID: 33390771.
      Citations: 4     Fields:    Translation:Humans
    6. Chen X, Huang J, Huang Y, Chen J, Huang Y, Jiang X, Shi Y. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China. Hum Immunol. 2020 Dec; 81(12):702-708. PMID: 32950268.
      Citations: 8     Fields:    Translation:HumansCells
    7. Liu B, Shi Y, Zhang W, Li R, He Z, Yang X, Pan Y, Deng X, Tan M, Zhao L, Zou F, Zhang Y, Pan T, Zhang J, Zhang X, Xiao F, Li F, Deng K, Zhang H. Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies. Cell Mol Immunol. 2020 10; 17(10):1098-1100. PMID: 32939033.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    8. Gong J, Ou J, Qiu X, Jie Y, Chen Y, Yuan L, Cao J, Tan M, Xu W, Zheng F, Shi Y, Hu B. A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China. Clin Infect Dis. 2020 07 28; 71(15):833-840. PMID: 32296824.
      Citations: 172     Fields:    Translation:HumansCellsPHPublic Health
    9. Tan M, Liu Y, Zhou R, Deng X, Li F, Liang K, Shi Y. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. Immunology. 2020 07; 160(3):261-268. PMID: 32460357.
      Citations: 79     Fields:    Translation:HumansCellsPHPublic Health